Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor  evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…

Ya está disponible para su consulta el artículo Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. The GOLD Randomized Clinical Trial Descárgalo aquí 

Descárgate aquí la Guía Dislipemias 2016

  El Doctor Elías Delgado, coordinador de Diabetes del Servicio de Endocrino del HUCA, participó el pasado mes de septiembre en el programa ‘Rueda por la Diabetes al Mont Blanc’, una ruta en bicicleta de montaña con personas con Diabetes Mellitus Tipo 1. El Doctor Delgado cuenta su experiencia en este post: El Tour del…

Está disponible para descarga el artículo Effect of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 1 Diabetes Using Insulin Injections.   Autores: RoyW. Beck, MD, PhD; Tonya Riddlesworth, PhD; Katrina Ruedy, MSPH; Andrew Ahmann, MD; Richard Bergenstal, MD; Stacie Haller, RD, LD, CDE; Craig Kollman, PhD; Davida Kruger, MSN, APN-BC; Janet B….

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians Descarga aquí el artículo